ABEONA THERAPEUTICS INC. Depreciation
ABEONA THERAPEUTICS INC. (ABEO) reported Depreciation of $700.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2023-05-11
- ABEONA THERAPEUTICS INC. depreciation for the quarter ending 2023-03-31 was $700.00K, a 12.50% decline year-over-year.
- ABEONA THERAPEUTICS INC. depreciation for the quarter ending 2022-03-31 was $800.00K.
- ABEONA THERAPEUTICS INC. depreciation for the quarter ending 2012-12-31 was $29.00K.
| Period end | Depreciation 3 month |
|---|---|
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-11 |
| 2022-03-31 | $800.00K 10-Q · filed 2023-05-11 |
| 2012-12-31 | $29.00K 10-K · filed 2013-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |